It didn’t take long for a new rising contender to appear since Pfizer’s last announcement of 90% efficiency in COVID-19 prevention. Moderna shares soared 16% in premarket trade on 16th Nov after the biotech company said its vaccine candidate met its primary endpoint in a Phase 3 trial, demonstrating a 94.5% success rate. In this clinical trial...
All eyes have been on America and now that the presidential election winner has been named, what can traders expect next? In this post, we will explore all the investment opportunities that may blossom from Biden’s election win. Signs have been clear when the global stocks rallied sharply on Monday, 9th Nov. Coupled with...
As the name suggests, Nonfarm Payrolls (NFP) is the measure of the number of workers in the United States that exclude: -farmworkers -private household employees -government employees -non-profit organization employees The reason why the aforementioned is excluded is because farm payroll is...
Since the first initial report of COVID-19 on 31st December 2019, when the WHO China Country Office was informed, there is finally some news of a promising breakthrough in the pharma scene. Eight months into the worst pandemic in a century, Pfizer Inc. and BioNTech SE paved a way with optimistic preliminary results in their vaccine studies....
When someone mentions a billion dollars, it may be difficult to fathom exactly how much the amount is. Many will probably imagine a vague concept of “a lot of money”. If we put a billion into numbers, it’s basically a thousand of a million and looks like this: 1,000,000,000. Now let’s say you have...